What is the ROCE (Return on Capital Employed) of Ono Pharmaceutical Co this year?
The ROCE of Ono Pharmaceutical Co is 0.2 undefined this year.
In 2024, Ono Pharmaceutical Co's return on capital employed (ROCE) was 0.2, a 19.74% increase from the 0.17 ROCE in the previous year.
Ono Pharmaceutical Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Analyzing Ono Pharmaceutical Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Ono Pharmaceutical Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Changes in Ono Pharmaceutical Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
The ROCE of Ono Pharmaceutical Co is 0.2 undefined this year.
The ROCE of Ono Pharmaceutical Co has increased by 19.74% increased compared to the previous year.
A high Return on Capital Employed (ROCE) indicates that Ono Pharmaceutical Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
A low ROCE (Return on Capital Employed) can indicate that Ono Pharmaceutical Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
An increase in the ROCE of Ono Pharmaceutical Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
A decrease in ROCE of Ono Pharmaceutical Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
Some factors that can affect Ono Pharmaceutical Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
The ROCE of Ono Pharmaceutical Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
To improve the ROCE, Ono Pharmaceutical Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
Over the past 12 months, Ono Pharmaceutical Co paid a dividend of 80 JPY . This corresponds to a dividend yield of about 3.6 %. For the coming 12 months, Ono Pharmaceutical Co is expected to pay a dividend of 86.14 JPY.
The current dividend yield of Ono Pharmaceutical Co is 3.6 %.
Ono Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.
Ono Pharmaceutical Co paid dividends every year for the past 23 years.
For the upcoming 12 months, dividends amounting to 86.14 JPY are expected. This corresponds to a dividend yield of 3.88 %.
Ono Pharmaceutical Co is assigned to the 'Health' sector.
To receive the latest dividend of Ono Pharmaceutical Co from 12/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
The last dividend was paid out on 12/1/2024.
In the year 2023, Ono Pharmaceutical Co distributed 77 JPY as dividends.
The dividends of Ono Pharmaceutical Co are distributed in JPY.
Our stock analysis for Ono Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ono Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.